Skip to Content
Merck
CN
  • Sporotrichosis successfully treated with terbinafine and potassium iodide: case report and review of the literature.

Sporotrichosis successfully treated with terbinafine and potassium iodide: case report and review of the literature.

Mycopathologia (2004-10-19)
Basak Coskun, Yunus Saral, Nusret Akpolat, Arzu Ataseven, Demet Ciçek
ABSTRACT

Sporotrichosis is rare in Turkey. We report a 40-year-old woman who had subcutaneous sporotrichosis caused by sporothrix schenckii that was successfully treated with terbinafine (250 mg, twice a day) for a period of 6 months. She received a saturated solution of potassium iodide orally for two months. Terbinafine and potassium iodide are suggested to be the agents of choice for treatment of subcutaneous sporotrichosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Potassium iodide, ≥99.99% trace metals basis
Sigma-Aldrich
Potassium iodide, AnhydroBeads, −10 mesh, 99.998% trace metals basis
Sigma-Aldrich
Potassium iodide, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
Potassium iodide, BioXtra, ≥99.0%
Sigma-Aldrich
Potassium iodide, suitable for plant cell culture
Sigma-Aldrich
Potassium iodide, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Potassium iodide, puriss., meets analytical specification of Ph. Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)
Sigma-Aldrich
Potassium iodide, puriss. p.a., reag. ISO, reag. Ph. Eur., ≥99.0%
Sigma-Aldrich
Potassium iodide, ReagentPlus®, 99%
Sigma-Aldrich
Potassium iodide, ACS reagent, ≥99.0%
Sigma-Aldrich
Gold etchant, standard